Conversely, the fibroblast growth factor FGF13 was 3-fold repressed at T4 treatment, and this factor is a novel regulator of NF-κB which potentiates cardiac hypertrophy [120]. This evidence concerns the gene NFKB1 and cardiac hypertrophy.